Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 5, 2016, Pages 832-838

  Jang, Min Kyung ^a   Yun, Ye Rang ^a   Kim, Seon Hoo ^a   Kim, A Ji Ha ^a   Jung, Myeong Ho ^a  

^a Pusan National University   (South Korea)

Author keywords

Endoplasmic reticulum (er) stress; Gomisin N; Hepatic steatosis; Inflammation; Lipogenesis

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; GOMISIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PALMITIC ACID; TRIACYLGLYCEROL; TUNICAMYCIN; X BOX BINDING PROTEIN 1; ACACA PROTEIN, HUMAN; ACETYL COENZYME A CARBOXYLASE; CYCLOOCTANE DERIVATIVE; CYTOKINE; DDIT3 PROTEIN, HUMAN; FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; HEAT SHOCK PROTEIN; LIGNAN; MOLECULAR CHAPERONE GRP78; POLYCYCLIC HYDROCARBON; PROTECTIVE AGENT; SCHIZANDRIN B; XBP1 PROTEIN, HUMAN;

ACC1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENDOPLASMIC RETICULUM STRESS; FAS GENE; FATTY LIVER; GENE; GENE EXPRESSION; GPAT GENE; HUMAN; IL 6 GENE; IN VITRO STUDY; IN VIVO STUDY; LIVER PROTECTION; LOW DRUG DOSE; MCP 1 GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TNF ALPHA GENE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HEP-G2 CELL LINE; LIVER; METABOLISM;

ACETYL-COA CARBOXYLASE; ANIMALS; CYCLOOCTANES; CYTOKINES; ENDOPLASMIC RETICULUM STRESS; FATTY ACID SYNTHASE, TYPE I; FATTY LIVER; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; LIGNANS; LIVER; MICE, INBRED C57BL; PALMITIC ACID; POLYCYCLIC COMPOUNDS; PROTECTIVE AGENTS; TRANSCRIPTION FACTOR CHOP; TRIGLYCERIDES; TUNICAMYCIN; X-BOX BINDING PROTEIN 1;

EID: 84968593896     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-01020     Document Type: Article

References (27)

1. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu. Rev. Biochem., 74, 739-789 (2005).
2. Tajiri S, Oyadomari S, Yano S, Morioka M, Gotoh T, Hamada JI, Ushio Y, Mori M. Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress pathway involving CHOP. Cell Death Differ., 11, 403-415 (2004).
3. Yamaguchi O, Higuchi Y, Hirotani S, Kashiwase K, Nakayama H, Hikoso S, Takeda T, Watanabe T, Asahi M, Taniike M, Matsumura Y, Tsujimoto I, Hongo K, Kusakari Y, Kurihara S, Nishida K, Ichijo H, Hori M, Otsu K. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc. Natl. Acad. Sci. U.S.A., 100, 15883-15888 (2003).
4. Araki E, Oyadomari S, Mori M. Endoplasmic reticulum stress and diabetes mellitus. Intern. Med., 42, 7-14 (2003).
5. Cao SS, Kaufman RJ. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin. Ther. Targets, 17, 437-448 (2013).
6. Park EC, Kim GH, Yun SH, Lim HL, Hong Y, Kwon SO, Kwon J, Chung YH, Kim SI. Analysis of the endoplasmic reticulum subproteome in the livers of type 2 diabetic mice. Int. J. Mol. Sci., 13, 17230-17243 (2012).
7. Passos E, Ascensão A, Martins MJ, Magalhães J. Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: The possible role of physical exercise. Metabolism, 64, 780-792 (2015).
8. Pagliassotti MJ. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu. Rev. Nutr., 32, 17-33 (2012).
9. Ashraf NU, Sheikh TA. Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease. Free Radic. Res., 49, 1405-1418 (2015).
10. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 43 (Suppl. 1), S99-S112 (2006).
11. Choi YW, Takamatsu S, Khan SI, Srinivas PV, Ferreira D, Zhao J, Khan IA. Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis structure-antioxidant activity relationships of dibenzocyclooctadiene. J. Nat. Prod., 69, 356-359 (2006).
12. Min HY, Park EJ, Hong JY, Kang YJ, Kim SJ, Chung HJ, Woo ER, Hung TM, Youn UJ, Kim YS, Kang SS, Bae K, Lee SK. Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells. Bioorg. Med. Chem. Lett., 18, 523-526 (2008).
13. Park HJ, Cho JY, Kim MK, Koh PO, Cho KW, Kim CH, Lee K-S, Chung BY, Kim G-S, Cho J-H. Anti-obesity effect of Schisandra chinensis in 3T3-L1 cells and high fat diet-induced obese rats. Food Chem., 134, 227-234 (2012).
14. Choi MS, Kwon KJ, Jeon SJ, Go HS, Kim KC, Ryu JR, Lee JM, Han SH, Cheong JH, Ryu JH, Shin KH, Ko CY. Schisandra chinensis alkaloids inhibit lipopolysaccharide-induced inflammatory responses in BV2 microglial cells. J. Biomol. Tech., 17, 47-56 (2009).
15. Chun JN, Cho M, So I, Jeon JH. The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia, 97, 224-233 (2014).
16. Hikino H, Kiso Y, Taguchi H, Ikeya Y. Antihepatotoxic actions of lignoids from Schisandra chinensis fruits. Planta Med., 50, 213-218 (1984).
17. Hwang IS, Kim JE, Lee YJ, Kwak MH, Choi YH, Kang BC, Hong JT, Hwang DY. Protective effects of gomisin A isolated from Schisandra chinensis against CCl(4)-induced hepatic and renal injury. Int. J. Mol. Med., 31, 888-898 (2013).
18. Kim SH, Kim YS, Kang SS, Bae K, Hung TM, Lee SM. Antiapoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J. Pharmacol. Sci., 106, 225-233 (2008).
19. Xue Y, Li X, Du X, Li X, Wang W, Yang J, Chen J, Pu J, Sun H. Isolation and anti-hepatitis B virus activity of dibenzocyclooctadiene lignans from the fruits of Schisandra chinensis. Phytochemistry, 116, 253-261 (2015).
20. Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. The constituents of Schizandra chinensis BAILL. I. Isolation and structure determination of five new lignans, Gomisin A, B, C, F and G, and the absolute structure of schizandrin. Chem. Pharm. Bull., 27, 1383-1394 (1979).
21. Heo JH, Park JG, Cheon HJ, Kim YS, Kang SS, Hung TM, Bae KH, Lee SM. Hepatoprotective activities of gomisin A and gomisin N. Korean J. Pharmacogn., 37, 294-301 (2006).
22. Kang K, Lee KM, Yoo JH, Lee HJ, Kim CY, Nho CW. Dibenzocyclooctadiene lignans, gomisins J and N inhibit the Wnt/β-catenin signaling pathway in HCT116 cells. Biochem. Biophys. Res. Commun., 428, 285-291 (2012).
23. Oh SY, Kim YH, Bae DS, Um BH, Pan CH, Kim CY, Lee HJ, Lee JK. Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci. Biotechnol. Biochem., 74, 285-291 (2010).
24. Chang CY, Chen YL, Yang SC, Huang GC, Tsi D, Huang CC, Chen JR, Li JS. Effect of schisandrin B and sesamin mixture on CCl(4)-induced hepatic oxidative stress in rats. Phytother. Res., 23, 251-256 (2009).
25. Ren F, Zhou L, Zhang X, Wen T, Shi H, Xie B, Li Z, Chen D, Wang Z, Duan Z. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure. Inflammation, 38, 1151-1165 (2015).
26. Lee JS, Zheng Z, Mendez R, Ha SW, Xie Y, Zhang K. Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. Toxicol. Lett., 211, 29-38 (2012).
27. Zhang Y, Xue R, Zhang Z, Yang X, Shi H. Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. Lipids Health Dis., 11, 1-8 (2012).